Jong Woo Hahn
서울대학교 의과대학 · 의학
정재우 한 교수의 연구실은 간질환의 전 세계적 부담을 분석하고, 특히 아프리카 지역의 간질환 관련 사망률 향상을 중심으로 공공보건 정책 수립에 기여하고 있습니다. 또한 담배 제조에 사용되는 첨가제가 흡연 제품의 성분과 연기 특성에 미치는 영향을 분석하여, 소비자 건강 위험과 중독성 증가 가능성에 대한 과학적 근거를 제공하고 있습니다. 연구는 주로 전 세계 보건 문제의 정량적 분석과 규제 정책 지원을 목표로 하며, 정책 결정에 기여하는 실용적 연구를 지향합니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
National Research Foundation of Korea.
PROSPERO (registration no. CRD42024527805).
Global age-standardized liver disease-related mortality has increased significantly and continues to emerge as a crucial global public health issue. Further investigation into liver disease-related mortality rates in Africa is needed, and updating policies is necessary to effectively manage the global burden of liver disease.
Abstract Additives used in tobacco product manufacturing are currently in the focus of public discussions with regard to potentially increased consumer health risks on account of certain additives. In addition, a few additives are suspected to enhance the addictiveness of tobacco products. In 2006, the German Federal Ministry for Food, Agriculture and Consumer Protection (BundesministeriumfuerErnaehrung, Landwirtschaft und Verbraucherschutz, BMELV) commissioned a research project intended to pro
Lifestyle modifications are fundamental in managing metabolic dysfunction-associated steatotic liver disease (MASLD). This study aimed to evaluate the effects of a 12-week lifestyle intervention on hepatic steatosis, liver function, and gut microbiota composition in pediatric MASLD patients, and to explore clinical and baseline microbial features associated with treatment response. A total of 40 patients were recruited, and 31 were included after applying exclusion criteria. After 12 weeks, sign
Supplementary Material 1.
Introduction: The incidence and severity of Clostridioides difficile infection (CDI) have been increasing over the past decades. It particularly contributes to acute exacerbations and worsen the severity of inflammatory bowel disease (IBD). Fecal microbiota transplantation (FMT) is one of standard treatments for recurrent CDI. The aim of this study was to evaluate the clinical outcome of FMT for recurrent CDI in pediatric patients with refractory IBD. Methods: From May 2013 through April 2023, w
Supplementary Material 1.
Supplementary Material 2.
Supplementary Material 2.
